Program: Education Program
Session: The Expanding Landscape of Treatment for ITP
Hematology Disease Topics & Pathways:
Combination therapy, Education, Therapy sequence, Treatment Considerations, Adverse Events
Session: The Expanding Landscape of Treatment for ITP
Hematology Disease Topics & Pathways:
Combination therapy, Education, Therapy sequence, Treatment Considerations, Adverse Events
Saturday, December 7, 2024, 9:30 AM-10:45 AM
Disclosures: Ghanima: HiBio: Consultancy; HUTCHMED: Consultancy; Takeda: Consultancy; Bristol Myers Squibb: Honoraria; Bayer: Honoraria; Hutchmed: Consultancy, Honoraria; Amgen: Consultancy, Honoraria; Grifols: Consultancy, Honoraria; Novartis: Consultancy, Honoraria; Sanofi: Consultancy, Honoraria, Research Funding; SOBI: Consultancy, Honoraria, Research Funding, Speakers Bureau; Kedrion: Consultancy; Alpine: Consultancy; Cellphire: Consultancy; Argenx: Consultancy, Honoraria; Alpine: Consultancy; Kedrion: Consultancy; Pfizer: Consultancy; Principia Biopharma Inc- a Sanofi Company: Consultancy; UCB: Consultancy; Argenx: Consultancy.
OffLabel Disclosure:
Previous Presentation
|
Next Presentation >>